Epigenetics in Development and Disease

joint with RNA Interference, Cosuppression and Related Phenomena

Organizer(s): Alan P. Wolffe, Stephen B. Baylin and Trevor K. Archer

For important information on the coronavirus, please click here

Summary of Meeting:

Remarkable progress is being made in appreciation and the role of epigenetics in topics as diverse as somatic gene therapy, cloning and transgenic strategies in plants and animals, aspects of cancer biology, the study of viral latency, the activity of mobile elements, genomic imprinting, and developmental abnormalities in animals and plants. Epigenetics presents a wonderful fusion of sciences relevant to human medicine, animal and plant biotech, and basic science. The excitement in this research area comes from the realization that diverse organisms have common molecular mechanisms that contribute to epigenetic control. This Keystone Symposium on 'Epigenetics in Development and Disease' will review the enormous progress and opportunities in this fast moving field. The meeting will have substantial representation from academic, medical and biotechnology perspectives. Therapeutic and commercial applications of epigenetics will be considered in depth.

Discounted Abstract Deadline: October 22 2001

Discounted Registration Deadline: December 20 2001

We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1 R13 CA94249-01

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations